Saliva-based Detection of CD44
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 300
Summary
- Conditions
- Oral Cavity Squamous Cell Carcinoma
- Oropharynx Squamous Cell Carcinoma
- Squamous Cell Carcinoma of the Head and Neck
- Squamous Cell Carcinoma of the Oropharynx
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
A noninvasive point of care salivary rinse test performed as 1) a one-time test for control subjects, 2) at pretreatment and post treatment 3,6, 12, and 18 month time points in oral cavity/oropharynx cancer patients
A noninvasive point of care salivary rinse test performed as 1) a one-time test for control subjects, 2) at pretreatment and post treatment 3,6, 12, and 18 month time points in oral cavity/oropharynx cancer patients
Tracking Information
- NCT #
- NCT03148665
- Collaborators
- Vigilant Biosciences, Inc.
- Greater Baltimore Medical Center
- San Diego Veterans Healthcare System
- NYU Langone Health
- Johns Hopkins University
- Investigators
- Study Chair: Joseph Califano, MD University of California, San Diego
Get Well Soon